Idaho Sci-Tech Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.

Press releases published on November 9, 2026

2 hours ago

Codexis Advances ECO Synthesis Toward Adoption Readiness with Quality at Scale and Expanded siRNA Manufacturing Capabilities

Indeterminate GlobeNewswire

2 hours ago

WILDx Mastermind and Media Day Brings Speakers Together for Branding, Media Training and National Exposure

Indeterminate GlobeNewswire

2 hours ago

Babeside Announces 2026 Black Friday Promotion for Reborn Baby Dolls

Indeterminate GlobeNewswire

3 hours ago

MIRAVA to Showcase M800E at boot Düsseldorf Ahead of European Sea Trial Tour

Indeterminate GlobeNewswire

3 hours ago

Epitopea Announces First Patient Dosed in OVACT Phase 1/1b Clinical Trial of CryptiVax™-1001 in Advanced High-Grade Serous Ovarian Cancer  

Indeterminate GlobeNewswire

3 hours ago

Epitopea annonce l'administration de la première dose à une patiente dans le cadre de l'essai clinique OVACT de phase 1/1b portant sur le CryptiVaxTM-1001 dans le cancer de l'ovaire séreux de haut grade avancé  

Indeterminate GlobeNewswire

3 hours ago

VapoLung Introduces VapoLung Spray, a Five-Ingredient Oral Dietary Supplement for Daily Respiratory Wellness

Indeterminate GlobeNewswire

3 hours ago

Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2026

Indeterminate GlobeNewswire

4 hours ago

Purple supports The King's Fund with guest WiFi at its London events venue

Indeterminate GlobeNewswire

5 hours ago

Bango and Ooredoo Group partner on subscription bundling across the Middle East, North Africa and Southeast Asia with the Digital Vending Machine®

Indeterminate GlobeNewswire

5 hours ago

OneKey Launches OneKey Neo: A $179 Hardware Wallet With a 3.54-Inch AMOLED Display and On-Device Portfolio View

Indeterminate GlobeNewswire

6 hours ago

Oculis to Host In-Person and Virtual R&D Day: Advancing a Differentiated Late-Stage Development Pipeline

Indeterminate GlobeNewswire

6 hours ago

GENFIT Highlights Data from Clinical Studies of Nangibotide, Supporting Its Advancement into ACLF with Phase 2 Data Expected in 2027

Indeterminate GlobeNewswire

6 hours ago

GENFIT présente les données issues des études cliniques de nangibotide soutenant la poursuite de son développement dans l’ACLF. Résultats de phase 2 attendus en 2027

Indeterminate GlobeNewswire

6 hours ago

Helping AI Recommend Quality Brands Accurately: Second GEO Conference Opens in Shenzhen on November 21

Indeterminate GlobeNewswire

7 hours ago

Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2

Indeterminate GlobeNewswire

7 hours ago

Valneva annonce des résultats positifs de phase 2 pour son candidat vaccin tétravalent contre la shigellose S4V2

Indeterminate GlobeNewswire

7 hours ago

Essential Pharma and Nordmark announce new partnership and UK availability of Norzyme® (pancreas powder) 25,000 gastro-resistant capsules for pancreatic exocrine insufficiency

Indeterminate GlobeNewswire

7 hours ago

argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities

Indeterminate GlobeNewswire

7 hours ago

ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE Using Novel Treatment Response Measure

Indeterminate GlobeNewswire